Stock Scorecard



Stock Summary for Hoth Therapeutics Inc (HOTH)

Total Score

13 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for HOTH

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for HOTH

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for HOTH

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for HOTH

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Financial Details for HOTH

Company Overview

Company Name Hoth Therapeutics Inc
Country USA
Description Hoth Therapeutics, Inc., a biopharmaceutical company, is focused on developing therapies for dermatological disorders. The company is headquartered in New York, New York.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 9/30/2022
Next Earnings Date 3/1/2023

Stock Price History

Last Day Price 3.91
Last Day Volume 12,204
Average Daily Volume 195,816
52-Week High 43.75
52-Week Low 3.47
Last Price to 52 Week Low 12.68 %

Valuation Measures

Trailing PE 0.00
Industry PE 38.49
Sector PE 93.33
5-Year Average PE -49.92
Free Cash Flow Ratio 0.57
Industry Free Cash Flow Ratio 8.26
Sector Free Cash Flow Ratio 37.81
Book Value Per Share Most Recent Quarter 6.68
Price to Book Ratio 0.63
Industry Price to Book Ratio 6.06
Sector Price to Book Ratio 15.40
Price to Sales Ratio Twelve Trailing Months 0.00
Industry Price to Sales Ratio Twelve Trailing Months 67.23
Sector Price to Sales Ratio Twelve Trailing Months 25.28

Share Statistics

Total Shares Outstanding 1,300,400
Market Capitalization 5,084,564
Institutional Ownership 0.00 %

Dividends

Ex-Dividend Date
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00 %
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00 %
5-Year Average Dividend Yield 0.00 %
5-Year Dividend Payments Count 0
Dividend Payout Ratio 0.00 %

Income Statement

Quarterly Earnings Growth YOY 0.00 %
Annual Earnings Growth -98.86 %
Reported EPS Past Year -7.05
Reported EPS Prior Year -16.50
Net Income Twelve Trailing Months -11,373,425
Net Income Past Year -14,313,705
Net Income Prior Year -7,197,816
Quarterly Revenue Growth YOY 0.00 %
5-Year Revenue Growth 0.00 %

Balance Sheet

Total Cash Per Share 6.87
Total Cash Most Recent Quarter 8,935,081
Total Cash Past Year 8,538,270
Total Cash Prior Year 2,629,670
Net Cash Position Most Recent Quarter 8,935,081
Net Cash Position Past Year 8,538,270
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Current Ratio Most Recent Quarter 9.43
Total Stockholder Equity Past Year 9,882,292
Total Stockholder Equity Prior Year 4,645,593
Total Stockholder Equity Most Recent Quarter 8,611,379

Options

Put/Call Ratio 0.00
Has Options False
Liquidity Rating None

Technical Analysis

MACD -0.65
MACD Signal -0.84
20-Day Bollinger Lower Band 2.75
20-Day Bollinger Middle Band 8.17
20-Day Bollinger Upper Band 13.59
Beta 0.76
RSI 32.26
50-Day SMA 12.42
200-Day SMA 0.00

System

Modified 12/3/2022 2:07:15 PM